JP2017502941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017502941A5 JP2017502941A5 JP2016538536A JP2016538536A JP2017502941A5 JP 2017502941 A5 JP2017502941 A5 JP 2017502941A5 JP 2016538536 A JP2016538536 A JP 2016538536A JP 2016538536 A JP2016538536 A JP 2016538536A JP 2017502941 A5 JP2017502941 A5 JP 2017502941A5
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- drug substance
- weight
- pharmaceutical formulation
- total weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915606P | 2013-12-13 | 2013-12-13 | |
| US61/915,606 | 2013-12-13 | ||
| PCT/IB2014/066820 WO2015087283A1 (en) | 2013-12-13 | 2014-12-11 | Pharmaceutical dosage forms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019082147A Division JP6804585B2 (ja) | 2013-12-13 | 2019-04-23 | 医薬剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017502941A JP2017502941A (ja) | 2017-01-26 |
| JP2017502941A5 true JP2017502941A5 (enExample) | 2018-01-25 |
| JP6522619B2 JP6522619B2 (ja) | 2019-05-29 |
Family
ID=52146563
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538536A Active JP6522619B2 (ja) | 2013-12-13 | 2014-12-11 | 医薬剤形 |
| JP2019082147A Active JP6804585B2 (ja) | 2013-12-13 | 2019-04-23 | 医薬剤形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019082147A Active JP6804585B2 (ja) | 2013-12-13 | 2019-04-23 | 医薬剤形 |
Country Status (33)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY194303A (en) | 2013-12-13 | 2022-11-27 | Novartis Ag | Pharmaceutical dosage forms |
| MA41611A (fr) * | 2015-02-23 | 2018-01-02 | Omthera Pharmaceuticals Inc | Préparations en milli-capsules comprenant des acides gras polyinsaturés libres |
| WO2019046167A1 (en) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
| MX2023007284A (es) * | 2020-12-18 | 2023-07-03 | Qed Therapeutics Inc | Metodos para el tratamiento de la acondroplasia. |
| WO2022194941A1 (en) * | 2021-03-17 | 2022-09-22 | Actelion Pharmaceuticals Ltd | Pharmaceutical dosage system |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
| NZ591443A (en) | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
| GEP20105074B (en) | 2005-12-21 | 2010-09-10 | Novartis Ag | Pyrimidinyl aryl urea derivatives being fgf inhibitors |
| FR2910813B1 (fr) * | 2006-12-28 | 2009-02-06 | Sanofi Aventis Sa | Nouvelle utilisation therapeutique pour le traitement des leucemies |
| AR079257A1 (es) * | 2009-12-07 | 2012-01-04 | Novartis Ag | Formas cristalinas de 3-(2,6-dicloro-3-5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas |
| KR20140040769A (ko) | 2011-07-01 | 2014-04-03 | 노파르티스 아게 | 조합 요법 |
| US9783504B2 (en) | 2013-07-09 | 2017-10-10 | Dana-Farber Cancer Institute, Inc. | Kinase inhibitors for the treatment of disease |
| MY194303A (en) | 2013-12-13 | 2022-11-27 | Novartis Ag | Pharmaceutical dosage forms |
| KR20170060042A (ko) | 2014-09-13 | 2017-05-31 | 노파르티스 아게 | Alk 억제제의 조합 요법 |
| WO2016151501A1 (en) | 2015-03-25 | 2016-09-29 | Novartis Ag | Pharmaceutical combinations |
| WO2016201370A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
-
2014
- 2014-12-11 MY MYPI2016701712A patent/MY194303A/en unknown
- 2014-12-11 PT PT148190846T patent/PT3079667T/pt unknown
- 2014-12-11 PL PL14819084T patent/PL3079667T3/pl unknown
- 2014-12-11 EP EP19181217.1A patent/EP3597179B1/en active Active
- 2014-12-11 NZ NZ719865A patent/NZ719865A/en unknown
- 2014-12-11 EP EP14819084.6A patent/EP3079667B1/en active Active
- 2014-12-11 SI SI201431315T patent/SI3079667T1/sl unknown
- 2014-12-11 SG SG10202104627UA patent/SG10202104627UA/en unknown
- 2014-12-11 TN TN2016000207A patent/TN2016000207A1/en unknown
- 2014-12-11 MX MX2016007652A patent/MX2016007652A/es active IP Right Grant
- 2014-12-11 JP JP2016538536A patent/JP6522619B2/ja active Active
- 2014-12-11 PE PE2016000773A patent/PE20160851A1/es unknown
- 2014-12-11 AU AU2014362999A patent/AU2014362999B2/en active Active
- 2014-12-11 AR ARP140104615A patent/AR098716A1/es not_active Application Discontinuation
- 2014-12-11 EA EA201691231A patent/EA036288B1/ru unknown
- 2014-12-11 KR KR1020167015239A patent/KR102349893B1/ko active Active
- 2014-12-11 HU HUE14819084A patent/HUE045156T2/hu unknown
- 2014-12-11 US US15/102,378 patent/US10278969B2/en active Active
- 2014-12-11 PH PH1/2016/501039A patent/PH12016501039B1/en unknown
- 2014-12-11 CN CN202310950714.8A patent/CN116942629A/zh active Pending
- 2014-12-11 DK DK14819084.6T patent/DK3079667T3/da active
- 2014-12-11 RS RSP20191178 patent/RS59270B1/sr unknown
- 2014-12-11 CA CA2930055A patent/CA2930055C/en active Active
- 2014-12-11 NZ NZ760002A patent/NZ760002A/en unknown
- 2014-12-11 CN CN201480067964.6A patent/CN105813635A/zh active Pending
- 2014-12-11 HR HRP20191691TT patent/HRP20191691T1/hr unknown
- 2014-12-11 ES ES14819084T patent/ES2745983T3/es active Active
- 2014-12-11 LT LTEP14819084.6T patent/LT3079667T/lt unknown
- 2014-12-11 WO PCT/IB2014/066820 patent/WO2015087283A1/en not_active Ceased
- 2014-12-11 MA MA39175A patent/MA39175A1/fr unknown
- 2014-12-12 TW TW103143546A patent/TWI721938B/zh active
- 2014-12-12 TW TW109136485A patent/TWI800759B/zh active
-
2016
- 2016-05-06 ZA ZA2016/03064A patent/ZA201603064B/en unknown
- 2016-05-18 IL IL245705A patent/IL245705B/en active IP Right Grant
- 2016-06-10 CL CL2016001436A patent/CL2016001436A1/es unknown
- 2016-07-13 EC ECIEPI201660194A patent/ECSP16060194A/es unknown
-
2019
- 2019-03-26 US US16/364,727 patent/US11160804B2/en active Active
- 2019-04-23 JP JP2019082147A patent/JP6804585B2/ja active Active
- 2019-09-23 CY CY20191100999T patent/CY1122063T1/el unknown
-
2021
- 2021-09-29 US US17/489,382 patent/US20220265651A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI856111B (zh) | 一種含有布魯頓氏酪胺酸激酶抑制劑的口服固體錠劑及其製備方法 | |
| JP2017502941A5 (enExample) | ||
| KR101977785B1 (ko) | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법 | |
| JP2007091758A5 (enExample) | ||
| JP6320371B2 (ja) | エンテカビルの医薬組成物および製造方法 | |
| RU2019138248A (ru) | Фармацевтическая композиция для перорального введения, содержащая энзалутамид | |
| CN104661649A (zh) | 包含替格瑞洛的固态口服医药制剂 | |
| JP2016536285A (ja) | アムロジピン及びバルサルタンを含む安定な医薬組成物 | |
| JP2013147470A (ja) | 口腔内崩壊錠 | |
| JP5614445B2 (ja) | 経口投与用粒子状医薬組成物 | |
| JP2011500811A5 (enExample) | ||
| KR101171375B1 (ko) | 난용성 약물을 함유하는 경구 제형 | |
| KR102349893B1 (ko) | 제약 투여 형태 | |
| CN102846573B (zh) | 水飞蓟宾双层缓释片及其制备方法 | |
| JP2013544272A5 (enExample) | ||
| JP2017520619A5 (enExample) | ||
| JP6379043B2 (ja) | カンデサルタンシレキセチル含有医薬組成物 | |
| JP6883401B2 (ja) | アジルサルタン含有錠剤及び錠剤におけるアジルサルタンの安定化方法 | |
| JP2016124861A (ja) | オルメサルタンメドキソミル含有口腔内崩壊錠 | |
| CN112057427B (zh) | 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法 | |
| CN101152155A (zh) | 盐酸伊伐布雷定固体药物组合物及其制备方法 | |
| WO2014122671A2 (en) | Solid oral compositions of saxagliptin | |
| JP6344678B2 (ja) | テルミサルタン含有製剤及びその製造方法 | |
| JP2010516712A5 (enExample) | ||
| TW202500155A (zh) | 雌激素受體降解劑之固體口服劑型 |